scispace - formally typeset
H

Hans Sanderson

Researcher at Aarhus University

Publications -  103
Citations -  3967

Hans Sanderson is an academic researcher from Aarhus University. The author has contributed to research in topics: Toxicity & Environmental exposure. The author has an hindex of 30, co-authored 96 publications receiving 3484 citations. Previous affiliations of Hans Sanderson include Roskilde University & University of Guelph.

Papers
More filters
Journal ArticleDOI

Ranking and prioritization of environmental risks of pharmaceuticals in surface waters.

TL;DR: Cardiovascular, gastrointestinal, antiviral, anxiolytic sedatives hypnotics and antipsychotics, corticosteroid, and thyroid pharmaceuticals were the predicted most hazardous therapeutic classes.
Journal ArticleDOI

Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening.

TL;DR: (Q)SAR's can be important prioritization tools for subsequent experimental risk assessment of pharmaceuticals in surface waters, due to the prevalent lack of ecotoxicological data.
Journal ArticleDOI

Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test.

TL;DR: Injury symptoms were comparatively uniform and consistent among chemical classes while degree of phytotoxicity varied considerably; both of these criteria varied markedly between classes.
Journal ArticleDOI

Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones

TL;DR: Q)SARs and pharmacodynamic information should be used to prioritize and steer experimental risk assessments of pharmaceuticals, and potentially, also be used in new drug discovery optimizing efficacy and in minimising environmental hazards of new products.
Journal ArticleDOI

Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum.

TL;DR: The microcosm data suggest that at an ecological effect size of >20%, biologically significant risks are low for L. gibba and M. sibiricum exposed to similar mixtures of pharmaceutical compounds, which is below the threshold value of 1 for chronic risks.